Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Breast cancer remains a major cause of morbidity and mortality among women worldwide, highlighting the necessity for predictive tools to identify at-risk individuals prior to the manifestation of symptoms. Standard imaging, like mammography, has limited sensitivity in dense breasts and relies on visible morphological changes. In contrast, circulating DNA methylation biomarkers provide a minimally ...
Chemoresistance to 5-fluorouracil (5-FU) remains a critical barrier in colorectal cancer (CRC) management. This study integrates multi-omics data from 26,192 human samples to elucidate the RNA methylation-mediated crosstalk between tumor-associated macrophages (TAMs) and tumor cells. Machine learning models were able to effectively stratify patients by risk and identified a core signature of six g...
Neoadjuvant therapy (NAT) is an important treatment strategy in surgical oncology, but not all patients benefit equally from it. This systematic revie...
Emerging evidence indicates that aberrant cholesterol metabolism in macrophages plays a role in tumorigenesis, however, how specific metabolites relea...
BACKGROUND: Regulated cell death programs influence melanoma progression and antitumor immunity, yet a robust prognostic model integrating multiple ce...
BACKGROUND: Pancreatic adenocarcinoma (PAAD) has an extremely poor prognosis, and existing prognostic markers fail to fully capture the complex hetero...
BACKGROUND: Leveraging deep learning on spatial transcriptomics data enables the identification of distinct spatial domains within tissues, thereby cl...
BACKGROUND: The ability to predict pathological complete response (pCR) prior to neoadjuvant therapy (NAT) would inform and facilitate tailored therap...
BACKGROUND: To evaluate the single-session agreement between treatment recommendations generated by ChatGPT and Gemini and real-world decisions made b...
BACKGROUND: Pathologic complete response (pCR) after neoadjuvant chemotherapy and dual HER2 blockade is associated with improved outcomes in HER2-posi...
Oncolytic viruses (OVs) represent a versatile platform for cancer immunotherapy, capable of selectively infecting and lysing tumor cells while trigger...
BACKGROUND: Vessels encapsulating tumor clusters (VETCs), a CD34-positive vascular pattern in hepatocellular carcinoma (HCC), are linked to aggressive...
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality, with transcatheter arterial chemoembolization (TACE) being a widel...
The 17th Annual Frontiers in Cancer Science (FCS) conference (2025) highlighted the convergence of multiomics, computational biology, and ancestry-spe...
BACKGROUND: Unstructured clinical text remains a major barrier to interoperable data reuse and large-scale secondary analysis in health care. Large la...
Chemotherapy-induced cardiotoxicity (CIC) remains a major cause of morbidity and mortality among cancer survivors, and conventional monitoring often f...
BACKGROUND: While artificial intelligence's (AI's) transformative potential in health care is widely acknowledged, its application in highly sensitive...
BACKGROUND AND OBJECTIVE: Metastatic hormone-sensitive prostate cancer (mHSPC) exhibits heterogeneous progression patterns, with early progression to ...
OBJECTIVE: Lung adenocarcinoma (LUAD) molecular heterogeneity limits traditional prognostic models. Given the emerging role of neural regulation (NR) ...